Leadership and Staff
![]() |
Wafaa El-Sadr, M.D., M.P.H.
HIV Center Associate Director Professor of Clinical Medicine and Epidemiology and Director of ICAP, Columbia University Mailman School of Public Health |
SELECTED PUBLICATIONS
1. Rabkin M, El-Sadr WM. Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Health. 2011;6(3):247-56.
2. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, Khan M, Pienaar J, El-Sadr W, Friedland G, Abdool Karim Q. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362(8):697-706. PMCID: PMC3076221.
3. El-Sadr WM, Affrunti M, Gamble T, Zerbe A. Antiretroviral therapy: A promising HIV prevention strategy? J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S116-S121. PMCID: PMC3074403.
4. El-Sadr WM, Mayer KH, Hodder SL. AIDS in America—forgotten but not gone. N Engl J Med. 2010;362:967¬-970.
5. Myer L, Carter RJ, Katyal M, Toro P, El-Sadr WM, Abrams EJ. Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: A cohort study. PLoS Med. 2010;7(2):e1000229. PMCID: PMC2817715.
6. Rabkin M, El-Sadr WM, Mugyenyi P, Ramatlapeng MK, De Cock KM. Lessons from Africa. J Acquir Immune Defic Syndr. 2010;55(Suppl 2): S141-S143.
7. Toro PL, Katyal M, Carter RJ, Myer L, El-Sadr WM, Nash D, Abrams EJ; for the MTCT-Plus Initiative. Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention. AIDS. 2010;24(4):515-524.
8. Abrams E, El-Sadr W. Lessons from Harlem: Relevance to a global epidemic. J Acquir Immune DeficSyndr. 2009;52(Suppl 1):S24-S26.
9. El-Sadr W, DeCock K. Health systems exist for real people. J Acquir Immune Defic Syndr. 2009;52(Suppl 1):S1-S2.
10. Rabkin M, El-Sadr W, DeCock K; for the Bellagio HIV/Health Systems Working Group. The impact of HIV scale-up on health systems: A priority research agenda. J Acquir Immune Defic Syndr. 2009;52(Suppl 1):S6-S11.
11. Remien RH, Chowdhury J, Mokhbat JE, Soliman C, Adawy ME, El-Sadr W. Gender and care: Access to HIV testing, care, and treatment. J Acquir Immune Defic Syndr. 2009;51(Suppl 3):S106-S110. PMCID: PMC2793673.
12. El-Sadr WM, Tsiouris SI. HIV-associated tuberculosis: Diagnostic and treatment challenges. Semin Respir Crit Care Med. 2008;29(5):525-531.
13. El-Sadr W, Abrams E. Scale-up of HIV care and treatment: Can it transform healthcare services in resource-limited settings? AIDS. 2007;21(Suppl 5):S65-S70.
14. Gasana M, Vandebriel G, Kabanda G, Mugabo J, Tsiouris SJ, Ayaba A, Finlay A, Justman J, Sahabo R, El-Sadr W. Tuberculosis in Rwanda: Challenges to reaching the targets. Bull World Health Organ. 2007;85(5):383-384.
15. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fätkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C. Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Eng J Med. 2006;355:2283-2296.
For further publications, visit PubMed and search for "El-Sadr WM"
HIV Center Associate Director
Professor of Clinical Medicine and Epidemiology and Director of ICAP, Columbia University Mailman School of Public Health
TEL: 212-939-2936
wme1@columbia.edu
Contact



